Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs Ondansetron for PONV in Pediatric Laparoscopic Surgery
NCT05439798Phase 3Unknown
- Sponsor
- Selçuk University
- Start
- Jun 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of palonosetron in postoperative nausea and vomiting (PONV), sponsored by Selçuk University. Status: unknown.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05439798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05439798.